0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Rofecoxib vs Celecoxib vs Acetaminophen for Treatment of Osteoarthritis

S. M. A. Bierma-Zeinstra, PhD; A. M. Bohnen, MD, PhD; M. Y. Berger, MD, PhD; S. Thomas, MD, PhD
JAMA. 2002;287(14):1799-1800. doi:10.1001/jama.287.14.1799.
Text Size: A A A
Published online

Extract

To the Editor: Dr Geba and colleagues1 reported that rofecoxib, 25 mg/d, was superior to celecoxib, 200 mg/d, and acetaminophen, 4000 mg/d, in treating osteoarthritis (OA) of the knee. We lack important information for supporting this conclusion.

First, it is known that patients are more likely to comply with once-daily regimens2 and that morning doses are less likely to be omitted.3 The report of the trial implied that the cyclooxygenase 2 (COX-2) inhibitors and their placebos were taken once daily, in the morning, while acetaminophen and its placebo were taken 4 times daily. Therefore, it is likely that suboptimal compliance had a large impact on the effect of acetaminophen. It would be helpful to the reader for the authors to report the compliance for the different groups, and to perform a subanalysis for efficacy in highly compliant patients.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();